The U.S. Food and Drug Administration and the Federal Trade Commission recently announced a collaboration to promote biosimilar competition. In a Law360 article published on Feb 19, life sciences regulatory and compliance partner Kellie Combs (Washington, D.C.) examines key aspects of the FDA/FTC collaboration and related FDA draft guidance regarding promotion of biologics and biosimilars, including implications for the biotechnology and life sciences industry.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.